Compare VanEck Gold Miners ETF (GDX) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Gold Miners ETF vs Immunovant Inc. Common Stock — how do they compare? VanEck Gold Miners ETF trades at $88.82 (market cap $25.65B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: VanEck Gold Miners ETF is far larger — about 3.9× Immunovant Inc. Common Stock's market cap, and VanEck Gold Miners ETF is more actively traded (20,709,928 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold VanEck Gold Miners ETF for 76 Days and Immunovant Inc. Common Stock for 0 Days on average.
| GDX | IMVT | |
|---|---|---|
Market Cap | $25.65B | $6.62B |
Volume | 20,709,928 | 1,131,364 |
52-Week High | $115.84 | $44.96 |
52-Week Low | $68.28 | $17.03 |
Typical Hold Time | 76 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $5.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDX trades at $85.46, down 3.13% today amid a bearish technical signal with 13 of 13 moving averages indicating sell signals. The ETF faces pressure from rising interest rates impacting dividend stocks and metals, with silver's sharp decline highlighting sector weakness. Recent news notes institutional selling by Allworth Financial and HB Wealth Management, though Ameritas Advisory increased its stake. Support sits at $84-$85, with resistance at $86-$87.
The outlook remains cautious due to bearish technicals and macro headwinds, but some analysts see value in gold miners' low valuations. Key risks include interest rate sensitivity and metals volatility, while potential catalysts include gold price stability and institutional accumulation. Investors should weigh technical weakness against long-term diversification benefits.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Gold Miners ETF
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
